Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandru B Constantinescu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Indian Journal of Ophthalmology|February 17, 2021
Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configurationCarol L Shields, Alexandru B Constantinescu, Sefy A Paulose, et al.
Cornea|December 4, 2020
Ocular Surface Squamous Neoplasia Managed With Primary Interferon α2b: A Comparative Analysis of 212 Tumors in Smokers Versus NonsmokersCarol L Shields, Sefy A Paulose, Antonio Yaghy, et al.
Middle East African Journal of Ophthalmology|August 21, 2018
Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor OriginCarol L Shields, R Joel Welch, Kunal Malik, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Indian Journal of Ophthalmology|February 17, 2021
Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configurationCarol L Shields, Alexandru B Constantinescu, Sefy A Paulose, et al.
Cornea|December 4, 2020
Ocular Surface Squamous Neoplasia Managed With Primary Interferon α2b: A Comparative Analysis of 212 Tumors in Smokers Versus NonsmokersCarol L Shields, Sefy A Paulose, Antonio Yaghy, et al.
Middle East African Journal of Ophthalmology|August 21, 2018
Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor OriginCarol L Shields, R Joel Welch, Kunal Malik, et al.
Pageof 1